Mirae Asset Global Etfs Holdings Ltd. Bridge Bio Pharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 95,326 shares of BBIO stock, worth $5.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
95,326
Previous 93,120
2.37%
Holding current value
$5.04 Million
Previous $3.22 Million
27.87%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
188MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$981 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$871 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$701 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$658 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$490 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.84B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...